November 14-15, 2022 | Washington, DC 


Learn about the latest technologies, partnerships and advances propelling the field of repurposing and re-shaping drug discovery and development


The next Drug Repositioning & Repurposing Conference will be taking place in Spring/Summer 2024. Please check back in the coming weeks and months for updates.

2014 Speakers

Anton Simeonov, Ph.D. (tentative), Acting Deputy Scientific Director, National Center for Advancing Translational Sciences, National Institutes of Health
Jerome B. Zeldis MD, Ph.D., Chief Medical Officer, Celgene Corp., CEO, Celgene Global Health
Craig D. Wegner, Ph.D., Executive Director, Translational Science, Emerging Innovations Unit, Scientific Partnering & Alliances, AstraZeneca Pharmaceuticals LP
Aris Persidis, Ph.D., President, Biovista
Joel Dudley, Ph.D., Assistant Professor of Genetics and Genomic Sciences, Director of Biomedical Informatics, Mount Sinai School of Medicine
Daniel Behr, MBA, Co-founder and Partner, Rediscovery Life Sciences
Bosun Hau, Partner, MVM Life Science Partners LLP
Dr. Robert Scoffin, Chief Executive Officer, Cresset, Co-Founder and CEO, Re-Pharm
Zhichao Liu, Ph. D., PI, Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (NCTR), FDA
Andrew Reaume, Ph.D., MBA, President & CEO, Melior Discovery, Inc.
Stephen Wong, Ph.D., PE, Founding Chair for Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, Weill Cornell Medical College at Texas Medical Center
Dr. Bruce Bloom, President and Chief Science Officer, Cures Within Reach
Neal M. Farber, Ph.D., Chief Executive Officer, NeuroHealing Pharmaceuticals, Inc.
Marc Foster, MBA, Chief Operating Officer, Transparency Life Sciences
Nicholas Sireau, Ph.D., Chairman and CEO, AKU Society, Co-Founder and Chairman, Findacure
Pankaj Agarwal, Ph.D., Director, Systematic Drug Repositioning (SyDR), QSci Computational Biology, RD Projects, Clinical Platforms, & Sciences, GlaxoSmithKline
Julie Blatt, MD, Professor,  Pediatric Hematology Oncology, University of North Carolina School of Medicine
Hermann Mucke, Ph.D. (virtual presenter), Chief Executive, H.M. Pharma Consultancy
Towia Libermann, Ph.D., Associate Professor of Medicine, Director, BIDMC Genomics, Proteomics, Bioinformatics, and Systems Biology Center, Beth Israel Deaconess Medical Center

Contact Us

Arrowhead Publishers
PO Box 96
Chanhassen, MN 55317


About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.